Join to View Full Profile
5323 Harry Hines BlvdDallas, TX 75390
Phone+1 214-648-0307
Dr. Nathani is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Rohit Nathani is an Internal Medicine specialist based in Dallas, TX, and a 2020 graduate of the All India Institute of Medical Sciences. His academic contributions include publications on topics such as the risk of trastuzumab deruxtecan-associated interstitial lung disease, long-term outcomes of peripheral artery disease in veterans, frailty in patients with adrenal adenomas, and glucocorticoid withdrawal syndrome. These studies have been published in respected journals such as the Journal of the National Comprehensive Cancer Network and the European Journal of Endocrinology.
Education & Training
University of Iowa Hospitals and ClinicsFellowship, Cardiovascular Disease, 2025
University of Texas Southwestern Medical CenterResidency, Internal Medicine, 2022 - 2025
All India Institute of Medical SciencesClass of 2020
Certifications & Licensure
American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- Long-Term Outcomes of Peripheral Artery Disease in Veterans: Analysis of the Peripheral Artery Disease Long-Term Survival Study (PEARLS).Saket Girotra, Qiang Li, Mary Vaughan-Sarrazin, Brian C Lund, Mohammad Al-Garadi
Journal of the American Heart Association. 2025-04-01 - CLO25-067: Risk of Trastuzumab Deruxtecan (T-DXd) Associated Interstitial Lung Disease (ILD)/Pneumonitis: A Real-World Population-Based Propensity-Matched Analysis.Parth Sharma, Piyush Nathani, Rohit Nathani, Anuj Shrestha
Journal of the National Comprehensive Cancer Network. 2025-03-28 - 1 citationsLong-term Outcomes of Peripheral Artery Disease In Veterans: Analysis of the PEripheral ARtery Disease Long-term Survival Study (PEARLS).Saket Girotra, Qiang Li, Mary Vaughan-Sarrazin, Brian C Lund, Mohammad Al-Garadi
Medrxiv. 2024-08-21
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
